Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring

• Status: Completed
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: All

Summary

There are clinical usefulness issues associated with bispectral index (BIS) for sedation of endoscopic submucosal dissection (ESD). However, the clinical usefulness of BIS for deep sedation is incompletely described. The purpose of this study is to show that BIS-guided sedation is safe and useful clinically and may provide stable sedation status to physicians and patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yonsei University
• Treatments: Propofol; Remifentanil

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists (ASA) physical status I to II.

Exclusion Criteria:

• body mass index (BMI) over 35 (Kg/m2)

• hepatic or renal insufficiency

• history of allergy to the drugs used

• history of administration of anxiolytics, narcotics, antipsychotics, opioid.